B7-h1 antigen - Open Access .click

Results 81 to 90 of about 545,026 (158)

Supplementary Table 1 and Supplementary Figures 1 through 3 from Myeloma Drug Resistance Induced by Binding of Myeloma B7-H1 (PD-L1) to PD-1

, 2016
Supplementary Table S1 Primer Sequence. Supplementary Figure S1. (A) Surface antigen expression and (B) Cell morphology of MOSTI-1 cells, and (C) drug sensitivity to melphalan and bortezomib of MOSTI-1, U266, and RPMI8226 cells.
Mika Sunakawa (15080250) +9 more
core +1 more source

Abstract A22: Temozolomide upregulates B7-H1 in glioma cells and promotes immunoressistance against T cells

, 2010
Temozolomide is widely used as the first-line chemotherapeutic agent for malignant glioma. However, it can prolong the median survival and progression-free survival in glioblastoma patients by only a few months.
Dwain K. Irvin +3 more
core +1 more source

Binding of miR-152 and miR-200b to B7-H1 mRNA.

, 2017
(A) Schematic of B7-H1 mRNA showing potential miR-152 and miR-200b binding sites in the 3’-UTR and schematic of the luciferase reporter. The complementary miR-152 and miR-200b binding sites in the B7-H1 3’ UTR were inserted downstream of a luciferase ...
Wei Li (7081) +11 more
core +1 more source

Identification of Galectin-9 (Gal-9) as a B7-H4 binding partner and characterization of their glycosylation-dependent interaction that modulates T cell signaling within a multi-ligand/receptor network. [PDF]

PLoS One
Wang RZ, Yang F, Sui J.
europepmc +1 more source

Co-stimulatory signal deficiency impairs cytotoxic T lymphocyte function in tumor immune evasion: molecular mechanisms and therapeutic implications. [PDF]